v3.26.1
Financial Instruments
 3 Months Ended
Mar. 31, 2026
Investments, All Other Investments [Abstract]  
Financial Instruments

3. Financial Instruments

 

The following table summarizes the Company’s cash and cash equivalents, amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant category reported as cash and cash equivalents and restricted cash as of March 31, 2026, and December 31, 2025:

 

   March 31, 2026 
   Reported as: 
(in thousands)  Cash and Cash
Equivalents		   Restricted Cash-
current		 
Cash  $1,005   $- 
Level 2          
Money market funds   13,611     -  
Subtotal   13,611    - 
Total assets measured at fair value  $14,616   $- 

 

   December 31, 2025 
   Reported as: 
(in thousands)  Cash and Cash
Equivalents		   Restricted Cash-
current		 
Cash  $1,325   $- 
Level 2          
Money market funds   12,096    - 
Subtotal   12,096    - 
Total assets measured at fair value  $13,421   $- 

 

Interest income recorded for these cash and investments was consistent at approximately $0.1 million and $0.5 million during the three months ended March 31, 2026, and the year ended December 31, 2025, respectively.

 

As of March 31, 2026, and December 31, 2025, the Company did not have any financial assets classified as Level 1 or Level 3. The contingent consideration is carried at fair value and is a Level 3 financial liability. See further discussion of the contingent consideration in Note 10 under the subheading “Access Point Technologies Share Purchase Agreement”.